CLASS II ONGOING Drug recall · Reported 8 Jul 2026 · FDA Enforcement Report

Trifluent Pharma Tridergel Wound Care Gel recalled by Blaine Labs

Blaine Labs is recalling Trifluent Pharma Tridergel Wound Care Gel, (Benzalkonium Chloride 0.1%) bottle with long, distributed nationwide in the US. The recall was initiated on 8 Apr 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: BL3435, Exp. 11/06/26
NDC73352-520
Quantity recalled519 - 1 oz bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0693-2026
FDA event ID
98731
Recalling firm
Blaine Labs, Santa Fe Springs, CA
Manufacturer
Trifluent Pharma LLC
Classification
Class II
Status
Ongoing
Recall initiated
8 Apr 2026
FDA classified
16 Jul 2026
Reported
8 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
Press Release

Timeline

8 Apr 2026Recall initiated by company
8 Jul 2026Published in enforcement report+91 days
16 Jul 2026Classified by FDA+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated

Product as listed by the FDA

TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated

Which lots are affected?

Lot #: BL3435, Exp. 11/06/26

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

7 other products · FDA event 98731

This product is part of a recall event; the main page for the event is Terpenicol Antifungal Solution, (Undecylenic recalled by Blaine Labs.

More recalls from Blaine Labs

All 9

Other Benzalkonium Chloride recalls

All 22